This prospective randomized Phase II study was designed to evaluate the preventive effect of an oral nutrition supplement composed of beta-hydroxy-beta-methylbutyrate , arginine and glutamine ( beta-hydroxy-beta-methylbutyrate / arginine/glutamine ) on radiation dermatitis in head and neck cancer patients .